Treatment of Patients and Mechanisms of Development of Combined of Urolithiasis and Kidney Tumors (Literature review)
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
Urolithiasis is a disease which is characterized by the formation of stones in the urinary system and is one of the most actual problems in modern urology and medicine worldwide. Recently, there has been a steady spread of this disease. Urolithiasis ranks the second position in the structure of urological diseases in Ukraine, second only to infectious and inflammatory pathologies and accounts for 30-45 % of diseases of the genitourinary system.
Urolithiasis is manifested by the appearance of stones in the urinary system (most often the kidneys). The most common type of kidney cancer (KC) is renal cell carcinoma. It accounts for about 97 % of all kidney tumors. With the increase in the number of patients with renal tumors and urolithiasis, there is a clear tendency to increase the number of patients with a combination of these two serious diseases. Unfortunately, the question of the relationship and interdependence between the development of urolithiasis and kidney tumor remains open today.
The objective: to search, systematize and analyze scientific publications about the mechanisms of development and treatment of this combined pathology.
Infection and chronic inflammation cause the development of urothelial proliferation and the emergence of malignant neoplasms. Inflammatory cells secrete cytokines and chemokines in response to a chronic recurrent infectious-inflammatory process that causes tumor cell growth and tumor progression. Special attention in the publications is paid to the role of endothelial dysfunction in the development of kidney tumors. The importance of vascular endothelial growth factor (VEGF) in the mechanism of neoangiogenesis of KC is demonstrated. Management of the patients with combined pathology of urolithiasis and KC involves the doctor’s choice of the optimal method.
The analysis of literature publications demonstrates that today there are a number of issues devoted to the presence of KC and urolithiasis in one patient. These are the risks of such a combination, and the mechanisms of development, as well as determining the most rational and effective management in each case.
All above mentioned cause the need for further study of the treatment of patients with urolithiasis and kidney tumor.
##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Najeeb Q, Masood I, Bhaskar N, Kaur H, Singh J, Pandey R, et al. Effect of BMI and urinary pH on urolithiasis and its composition. Saudi J Kidney Dis Transpl. 2013;24(1):60–6. doi: 10.4103/1319-2442.106243
Apolihin OI, Sivkov AV, Moskaleva NG, Beshliev DA, Solnceva TV, Komarova VA. Analiz urologicheskoj zabolevaemosti i smertnosti v Rossijskoj Federacii za desyatiletnij period (2002–2012). Eksperimental i Klin Urol. 2014;2:4–12.
Ljungberg B, Campbell SC, Choi HY, Jacqmin D, Lee JE, Weikert S, et al. The epidemiology of renal cell carcinoma. Eur Urol. 2011;60(4):615–21. doi: 10.14740/wjon1279
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374–403. doi: 10.1016/j.ejca.2012.12.027
Solarek W, Czarnecka AM, Escudier B. Insulin and IGFs in renal cancer risk and progression. Endocr Relat Cancer. 2015;22(5):253–64. doi: 10.1530/ERC-15-0135
Alyaev YUG, Amosov AV, Grigoryan VA, Grigoryan ZG, Abdusalamov AF. Gigantskaya opuhol pochki i kamen protivopolozhnogo mochetochnika. Med zhurnal “SonoAce – ultrasound”. 2002;10:27–30.
Chung SD, Liu SP, Lin HC. A population-based study on the association between urinary calculi and kidney cancer. Can Urol Assoc J. 2013;7(11-12):716–21. doi: 10.5489/cuaj.366
Sun LM, Lin CL, Chang YJ, Liang JA, Liu SH, Sung FC, et al. Urinary tract stone raises subsequent risk for urinary tract cancer: a population-based cohort study. BJU Int. 2013;112 (8):1150–5. doi: 10.1111/bju.12402
Manzanila-Garcіa HA, Lira-Dale A, Rosas-Nava E, Almanza-Gonzаlez MS. Nephron-sparing for clear cell carcinoma in a solitary functional kidney. Casereport and literature review. Cir Cir. 2011;79(2):196–201.
Volavšek M, Strojan-Flezar M, Mikuz G. Thyroid-like follicular carcinoma of the kidney in a patient with nephrolithiasis and polycystic kidney disease: a case report. Diagn Pathol. 2013;8(108):1138–49. doi: 10.1186/1746-1596-8-108
Chow WH, Lindblad P, Gridley G, Nyren O, Mc. Laughlin JK, Linet MS, et al. Risk of urinary tract cancers following kidney or ureter stones. J Nate Cancer Inst. 1997;89(19):1453–7. doi: 10.1093/jnci/89.19.1453
Alyaev YUG, Grigoryan ZG, Krapivin AA. Opuhol pochki v sochetanii s mochekamennoj bolezn’yu. Monografiya. Moskva: Klinika urologii MMA im. I.M. Sechenova; 2005. 224 p.
Li WM, Chou YH, Li CC, Liu CC, Huang SP, Wu WJ, et al. Association of body mass index and urine pH in patients with urolithiasis. Urol Res. 2009;37(4):193–6. doi: 10.1007/s00240-009-0194-4
Alyaev YUG, Pshihachev AM, SHpot EV, Akopyan GN, Proskura AV. Opuhol pochki I mochekamennaya bolezn: sushchestvuet li vzaimosvyaz? Urol. 2016;3:104–8.
Chia J, Yung T, Shuo M, Wu C, Tzeng J, Der C. Urinary calculi and risk of cancer: a nation-wide population-based study. Medicina (Baltimore). 2014;93(29):342–53. doi: 10.1097/MD.0000000000000342
Trapeznikova MF, Dutov VV, Urenkov SB, Kulachkov SM, Mezencev VA. Taktika lecheniya bolnyh pri sochetanii opuholi pochki i mochekamennoj bolezni. Urol i Nefrol. 1995;6:18–22.
Cheungpasitporn W, Thongprayoon C, O’Corragain OA, Edmonds PJ, Ungprasert P, Kittanamongkolchai W, et al. The risk of kidney cancer in patients with kidney stones: a systematic review and metaanalysis. QJ Med. 2015;108(3):205–12. doi: 10.1093/qjmed/hcu195
Zharinova VYU. Endotelialnaya disfunkciya kak multidisciplinarnaya problema. Krovoobіg і Gomeostaz. 2015;4:87–95.
Sergienko IV, Semenova AE, Masenko VP. Vliyanie terapii statinami na dinamiku urovnej sosudistogo endotelialnogo faktora rosta i faktora rosta fibroblastov u bolnyh IBS. Kardiol. 2007;8:4–7.
Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end stage renal failure. J Am Soc Nephrol. 2006;17(1):17–25. doi: 10.1681/ASN.2005070757
Apanovich NV, Peters MV, Korotaeva AA, Apanovich PV, Markova AS, Kamolov BSH, et al. Molekulyarno-geneticheskaya diagnostika svetlokletochnogo pochechno-kletochnogo raka. Onkourol. 2016;12(4):16–21.
Rini BI, Campbell SC, Escudier B. Renal cell carcinoma. Mar. 2009;28;373(9669):1119–132.
Harchenko EP. Kancerogenez: immunnaya sistema i immunoterapiya. Immunol. 2011;32(1):50–6.
Eruslanov E, Stoffs T, Kim WJ. Expansion of inflammatory CCR8 myeloid cells in patients with renal and urothelial carcinomas. Clin Cancer Res. 2013;19(7):1670–80. doi: 10.1158/1078-0432.CCR-12-2091
Gasanov MZ, Batyushin MM, Terentev VP, Cvetkov DS, Pasechnik DG. Molekulyarnye aspekty patogeneza raka pochki. Fundamentalnye issledovaniya. 2012;12:244–9.
Rini BI, Small EJ. Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma. J Clin Oncol. 2005;23:1028–43. doi: 10.1200/JCO.2005.01.186
Shibuya M. Vascular endothelial growth factor receptor-1: a dual regulator for angiogenesis. Angiogenesis. 2006;9(4):225–30. doi: 10.1007/s10456-006-9055-8
Kushlinskij NE, Gershtejn ES. Biologicheskie markery opuholej v klinike – dostizheniya, problemy, perspektivy. Molekulyarnaya Medicina. 2008;3:48–56.
Trapeznikova MF, Glybin PV, Tumanyan VG, Gershtejn ES, Dutov VV, Kushlinskij NE. Faktor rosta endoteliya sosudov i ego receptorov v syvorotke krovi i v opuholi bolnyh rakom pochki. Klin Gerontol. 2011;9-10:14–19.
Nikolskij YUE, CHehonackaya ML, Zaharova NB, Popyhova EB, Ponukalin AN. Magnitno-rezonansnaya tomografiya i biomarkery syvorotki krovi i mochi v diagnostike raka pochki. Saratovskij nauchno-medicinskij zhurn. 2016;12(1):52–6.
Glybochko PV, Svistunov AA, Rossolovskij AN, Ponukalin AN, Zaharova NB, Blyumberg BI, et al. Endotelial’naya disfunkciya u bol’nyh mochekamennoj boleznyu. Urol. 2010:3:3–6.
Pshihachev AM, Alyaev YUG. Opuhol pochki u bolnyh mochekamennoj boleznyu: sovremennoe sostoyanie problemy. Urolog. 2016;6:149–51.
Minervini A, Ficarra V, Rocco F, Antonelli A, Bertini R, Carmignani G, et al. Simple enucleation is equivalent to traditional partial nephrectomy for renal cell carcinoma: results of a non-randomized, retrospective, comparative study. J Urol. 2011;185(5):1604–10. doi: 10.1016/j.juro.2010.12.048
Laryngakis NA, Guzzo TJ. Tumor enucleation for small renal masses. Curr Opin Urol. 2012;22(5):365–71. doi: 10.1097/MOU.0b013e3283551f84
Shpot EV, Glybochko PV, Alyaev YUG, Petrovskij NV, Fiev DN, Pshihachev AM, et al. Otkrytaya i laparoskopicheskaya enukleaciya opuholi pochki. Urol. 2014;5:67–71.
Shpot EV, Pshihachev AM. Principy hirurgicheskogo lecheniya bolnyh opuholyu pochki v sochetanii s kamnem protivopolozhnoj pochki. Urol. 2016;6:76–83.
Kochkin AD, Sevryukov FA, Sorokin DA, Karpuhin IV, Puchkin AB, et al. Sochetannye laparoskopicheskie operacii na pochke: dva v odnom. Eksperimentali klin Urol. 2013;4:82–4.
Glybochko PV, Alyaev YUG, Pshihachev AM, Shpot EV, Sorokin NI, Dymov AM. Vozmozhnosti endovideohirurgicheskih tekhnologij pri ipsilateral’nom sochetanii opuholi I kamnya v pochke. Urol. 2016;3:70–5.
